Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Total 13F shares
-
1,198,078,929
-
Share change
-
-13,800,644
-
Total reported value
-
$104,873,409,014
-
Put/Call ratio
-
139%
-
Price per share
-
$87.59
-
Number of holders
-
2,337
-
Value change
-
-$1,244,500,321
-
Number of buys
-
1,122
-
Number of sells
-
1,017
Institutional Holders of AbbVie Inc. - Common Stock (ABBV) as of Q3 2020
As of 30 Sep 2020,
AbbVie Inc. - Common Stock (ABBV) was held by
2,337 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,198,078,929 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Capital Research Global Investors, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and Berkshire Hathaway Inc.
This page lists
2,353
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.